ARCHIVES

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says

September 29, 1978

Biotheraputices To Reveal Plans for Expansion

August 8, 1986